Publication | Open Access

Disease modifying effect of chronic oral treatment with a neurotrophic peptidergic compound in a triple transgenic mouse model of Alzheimer's disease

Alzheimer's DiseaseMedicineDementiaChronic Oral TreatmentNeuropharmacologyNeurochemical BiomarkersNeuroprotectionNeurologyNeuroscienceNeurodegenerationPharmacologyNeurotrophic Peptidergic CompoundNeuropeptides